Global Genetic Testing for Safe Medication Market Size, Status and Forecast 2021-2027

安全投薬用遺伝子検査の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Genetic Testing for Safe Medication Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2256
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:98
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、安全投薬用遺伝子検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(口腔粘膜コレクション、FTA血液サンプルコレクション)、用途別市場規模(病院、診療所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・安全投薬用遺伝子検査の市場動向
・企業の競争状況、市場シェア
・安全投薬用遺伝子検査の種類別市場規模(口腔粘膜コレクション、FTA血液サンプルコレクション)
・安全投薬用遺伝子検査の用途別市場規模(病院、診療所)
・安全投薬用遺伝子検査の北米市場規模2016-2027(アメリカ、カナダ)
・安全投薬用遺伝子検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・安全投薬用遺伝子検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・安全投薬用遺伝子検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・安全投薬用遺伝子検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Premed、Inmedi、Yin Feng Gene、United Gene Group、KingMed、Geneis、Sansure)
・結論

It is a method to interpret the genetic codes related to drug reactions and predict the degree of adverse reactions of patients to different drugs

Market Analysis and Insights: Global Genetic Testing for Safe Medication Market
The global Genetic Testing for Safe Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Testing for Safe Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Testing for Safe Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Testing for Safe Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Testing for Safe Medication market.

Global Genetic Testing for Safe Medication Scope and Market Size
Genetic Testing for Safe Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Testing for Safe Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Mucosa Collection
FTA Blood Sample Collection

Segment by Application
Hospital
Clinic

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Premed
Inmedi
Yin Feng Gene
United Gene Group
KingMed
Geneis
Sansure

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Testing for Safe Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Mucosa Collection
1.2.3 FTA Blood Sample Collection
1.3 Market by Application
1.3.1 Global Genetic Testing for Safe Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genetic Testing for Safe Medication Market Perspective (2016-2027)
2.2 Genetic Testing for Safe Medication Growth Trends by Regions
2.2.1 Genetic Testing for Safe Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genetic Testing for Safe Medication Historic Market Share by Regions (2016-2021)
2.2.3 Genetic Testing for Safe Medication Forecasted Market Size by Regions (2022-2027)
2.3 Genetic Testing for Safe Medication Industry Dynamic
2.3.1 Genetic Testing for Safe Medication Market Trends
2.3.2 Genetic Testing for Safe Medication Market Drivers
2.3.3 Genetic Testing for Safe Medication Market Challenges
2.3.4 Genetic Testing for Safe Medication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genetic Testing for Safe Medication Players by Revenue
3.1.1 Global Top Genetic Testing for Safe Medication Players by Revenue (2016-2021)
3.1.2 Global Genetic Testing for Safe Medication Revenue Market Share by Players (2016-2021)
3.2 Global Genetic Testing for Safe Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genetic Testing for Safe Medication Revenue
3.4 Global Genetic Testing for Safe Medication Market Concentration Ratio
3.4.1 Global Genetic Testing for Safe Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Testing for Safe Medication Revenue in 2020
3.5 Genetic Testing for Safe Medication Key Players Head office and Area Served
3.6 Key Players Genetic Testing for Safe Medication Product Solution and Service
3.7 Date of Enter into Genetic Testing for Safe Medication Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Testing for Safe Medication Breakdown Data by Type
4.1 Global Genetic Testing for Safe Medication Historic Market Size by Type (2016-2021)
4.2 Global Genetic Testing for Safe Medication Forecasted Market Size by Type (2022-2027)

5 Genetic Testing for Safe Medication Breakdown Data by Application
5.1 Global Genetic Testing for Safe Medication Historic Market Size by Application (2016-2021)
5.2 Global Genetic Testing for Safe Medication Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genetic Testing for Safe Medication Market Size (2016-2027)
6.2 North America Genetic Testing for Safe Medication Market Size by Type
6.2.1 North America Genetic Testing for Safe Medication Market Size by Type (2016-2021)
6.2.2 North America Genetic Testing for Safe Medication Market Size by Type (2022-2027)
6.2.3 North America Genetic Testing for Safe Medication Market Size by Type (2016-2027)
6.3 North America Genetic Testing for Safe Medication Market Size by Application
6.3.1 North America Genetic Testing for Safe Medication Market Size by Application (2016-2021)
6.3.2 North America Genetic Testing for Safe Medication Market Size by Application (2022-2027)
6.3.3 North America Genetic Testing for Safe Medication Market Size by Application (2016-2027)
6.4 North America Genetic Testing for Safe Medication Market Size by Country
6.4.1 North America Genetic Testing for Safe Medication Market Size by Country (2016-2021)
6.4.2 North America Genetic Testing for Safe Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Genetic Testing for Safe Medication Market Size (2016-2027)
7.2 Europe Genetic Testing for Safe Medication Market Size by Type
7.2.1 Europe Genetic Testing for Safe Medication Market Size by Type (2016-2021)
7.2.2 Europe Genetic Testing for Safe Medication Market Size by Type (2022-2027)
7.2.3 Europe Genetic Testing for Safe Medication Market Size by Type (2016-2027)
7.3 Europe Genetic Testing for Safe Medication Market Size by Application
7.3.1 Europe Genetic Testing for Safe Medication Market Size by Application (2016-2021)
7.3.2 Europe Genetic Testing for Safe Medication Market Size by Application (2022-2027)
7.3.3 Europe Genetic Testing for Safe Medication Market Size by Application (2016-2027)
7.4 Europe Genetic Testing for Safe Medication Market Size by Country
7.4.1 Europe Genetic Testing for Safe Medication Market Size by Country (2016-2021)
7.4.2 Europe Genetic Testing for Safe Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genetic Testing for Safe Medication Market Size (2016-2027)
8.2 Asia-Pacific Genetic Testing for Safe Medication Market Size by Type
8.2.1 Asia-Pacific Genetic Testing for Safe Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genetic Testing for Safe Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genetic Testing for Safe Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific Genetic Testing for Safe Medication Market Size by Application
8.3.1 Asia-Pacific Genetic Testing for Safe Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genetic Testing for Safe Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genetic Testing for Safe Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific Genetic Testing for Safe Medication Market Size by Region
8.4.1 Asia-Pacific Genetic Testing for Safe Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genetic Testing for Safe Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genetic Testing for Safe Medication Market Size (2016-2027)
9.2 Latin America Genetic Testing for Safe Medication Market Size by Type
9.2.1 Latin America Genetic Testing for Safe Medication Market Size by Type (2016-2021)
9.2.2 Latin America Genetic Testing for Safe Medication Market Size by Type (2022-2027)
9.2.3 Latin America Genetic Testing for Safe Medication Market Size by Type (2016-2027)
9.3 Latin America Genetic Testing for Safe Medication Market Size by Application
9.3.1 Latin America Genetic Testing for Safe Medication Market Size by Application (2016-2021)
9.3.2 Latin America Genetic Testing for Safe Medication Market Size by Application (2022-2027)
9.3.3 Latin America Genetic Testing for Safe Medication Market Size by Application (2016-2027)
9.4 Latin America Genetic Testing for Safe Medication Market Size by Country
9.4.1 Latin America Genetic Testing for Safe Medication Market Size by Country (2016-2021)
9.4.2 Latin America Genetic Testing for Safe Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genetic Testing for Safe Medication Market Size (2016-2027)
10.2 Middle East & Africa Genetic Testing for Safe Medication Market Size by Type
10.2.1 Middle East & Africa Genetic Testing for Safe Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genetic Testing for Safe Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genetic Testing for Safe Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa Genetic Testing for Safe Medication Market Size by Application
10.3.1 Middle East & Africa Genetic Testing for Safe Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genetic Testing for Safe Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genetic Testing for Safe Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa Genetic Testing for Safe Medication Market Size by Country
10.4.1 Middle East & Africa Genetic Testing for Safe Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genetic Testing for Safe Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Genetic Testing for Safe Medication Introduction
11.1.4 Premed Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.1.5 Premed Recent Development
11.2 Inmedi
11.2.1 Inmedi Company Details
11.2.2 Inmedi Business Overview
11.2.3 Inmedi Genetic Testing for Safe Medication Introduction
11.2.4 Inmedi Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.2.5 Inmedi Recent Development
11.3 Yin Feng Gene
11.3.1 Yin Feng Gene Company Details
11.3.2 Yin Feng Gene Business Overview
11.3.3 Yin Feng Gene Genetic Testing for Safe Medication Introduction
11.3.4 Yin Feng Gene Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.3.5 Yin Feng Gene Recent Development
11.4 United Gene Group
11.4.1 United Gene Group Company Details
11.4.2 United Gene Group Business Overview
11.4.3 United Gene Group Genetic Testing for Safe Medication Introduction
11.4.4 United Gene Group Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.4.5 United Gene Group Recent Development
11.5 KingMed
11.5.1 KingMed Company Details
11.5.2 KingMed Business Overview
11.5.3 KingMed Genetic Testing for Safe Medication Introduction
11.5.4 KingMed Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.5.5 KingMed Recent Development
11.6 Geneis
11.6.1 Geneis Company Details
11.6.2 Geneis Business Overview
11.6.3 Geneis Genetic Testing for Safe Medication Introduction
11.6.4 Geneis Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.6.5 Geneis Recent Development
11.7 Sansure
11.7.1 Sansure Company Details
11.7.2 Sansure Business Overview
11.7.3 Sansure Genetic Testing for Safe Medication Introduction
11.7.4 Sansure Revenue in Genetic Testing for Safe Medication Business (2016-2021)
11.7.5 Sansure Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Genetic Testing for Safe Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Mucosa Collection
Table 3. Key Players of FTA Blood Sample Collection
Table 4. Global Genetic Testing for Safe Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Genetic Testing for Safe Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genetic Testing for Safe Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Genetic Testing for Safe Medication Market Share by Regions (2016-2021)
Table 8. Global Genetic Testing for Safe Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Genetic Testing for Safe Medication Market Share by Regions (2022-2027)
Table 10. Genetic Testing for Safe Medication Market Trends
Table 11. Genetic Testing for Safe Medication Market Drivers
Table 12. Genetic Testing for Safe Medication Market Challenges
Table 13. Genetic Testing for Safe Medication Market Restraints
Table 14. Global Genetic Testing for Safe Medication Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Genetic Testing for Safe Medication Market Share by Players (2016-2021)
Table 16. Global Top Genetic Testing for Safe Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Testing for Safe Medication as of 2020)
Table 17. Ranking of Global Top Genetic Testing for Safe Medication Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Genetic Testing for Safe Medication Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Genetic Testing for Safe Medication Product Solution and Service
Table 21. Date of Enter into Genetic Testing for Safe Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Genetic Testing for Safe Medication Revenue Market Share by Type (2016-2021)
Table 25. Global Genetic Testing for Safe Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Genetic Testing for Safe Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Genetic Testing for Safe Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Genetic Testing for Safe Medication Revenue Market Share by Application (2016-2021)
Table 29. Global Genetic Testing for Safe Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Genetic Testing for Safe Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Genetic Testing for Safe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Genetic Testing for Safe Medication Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Genetic Testing for Safe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Genetic Testing for Safe Medication Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Genetic Testing for Safe Medication Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Genetic Testing for Safe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Genetic Testing for Safe Medication Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Genetic Testing for Safe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Genetic Testing for Safe Medication Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Genetic Testing for Safe Medication Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Genetic Testing for Safe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Genetic Testing for Safe Medication Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Genetic Testing for Safe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Genetic Testing for Safe Medication Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Genetic Testing for Safe Medication Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Genetic Testing for Safe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Genetic Testing for Safe Medication Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Genetic Testing for Safe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Genetic Testing for Safe Medication Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Genetic Testing for Safe Medication Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Genetic Testing for Safe Medication Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Genetic Testing for Safe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Genetic Testing for Safe Medication Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Genetic Testing for Safe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Genetic Testing for Safe Medication Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Genetic Testing for Safe Medication Market Size by Country (2022-2027) & (US$ Million)
Table 61. Premed Company Details
Table 62. Premed Business Overview
Table 63. Premed Genetic Testing for Safe Medication Product
Table 64. Premed Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 65. Premed Recent Development
Table 66. Inmedi Company Details
Table 67. Inmedi Business Overview
Table 68. Inmedi Genetic Testing for Safe Medication Product
Table 69. Inmedi Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 70. Inmedi Recent Development
Table 71. Yin Feng Gene Company Details
Table 72. Yin Feng Gene Business Overview
Table 73. Yin Feng Gene Genetic Testing for Safe Medication Product
Table 74. Yin Feng Gene Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 75. Yin Feng Gene Recent Development
Table 76. United Gene Group Company Details
Table 77. United Gene Group Business Overview
Table 78. United Gene Group Genetic Testing for Safe Medication Product
Table 79. United Gene Group Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 80. United Gene Group Recent Development
Table 81. KingMed Company Details
Table 82. KingMed Business Overview
Table 83. KingMed Genetic Testing for Safe Medication Product
Table 84. KingMed Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 85. KingMed Recent Development
Table 86. Geneis Company Details
Table 87. Geneis Business Overview
Table 88. Geneis Genetic Testing for Safe Medication Product
Table 89. Geneis Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 90. Geneis Recent Development
Table 91. Sansure Company Details
Table 92. Sansure Business Overview
Table 93. Sansure Genetic Testing for Safe Medication Product
Table 94. Sansure Revenue in Genetic Testing for Safe Medication Business (2016-2021) & (US$ Million)
Table 95. Sansure Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Testing for Safe Medication Market Share by Type: 2020 VS 2027
Figure 2. Oral Mucosa Collection Features
Figure 3. FTA Blood Sample Collection Features
Figure 4. Global Genetic Testing for Safe Medication Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Genetic Testing for Safe Medication Report Years Considered
Figure 8. Global Genetic Testing for Safe Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Genetic Testing for Safe Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Genetic Testing for Safe Medication Market Share by Regions: 2020 VS 2027
Figure 11. Global Genetic Testing for Safe Medication Market Share by Regions (2022-2027)
Figure 12. Global Genetic Testing for Safe Medication Market Share by Players in 2020
Figure 13. Global Top Genetic Testing for Safe Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Testing for Safe Medication as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Genetic Testing for Safe Medication Revenue in 2020
Figure 15. Global Genetic Testing for Safe Medication Revenue Market Share by Type (2016-2021)
Figure 16. Global Genetic Testing for Safe Medication Revenue Market Share by Type (2022-2027)
Figure 17. North America Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Genetic Testing for Safe Medication Market Share by Type (2016-2027)
Figure 19. North America Genetic Testing for Safe Medication Market Share by Application (2016-2027)
Figure 20. North America Genetic Testing for Safe Medication Market Share by Country (2016-2027)
Figure 21. United States Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Genetic Testing for Safe Medication Market Share by Type (2016-2027)
Figure 25. Europe Genetic Testing for Safe Medication Market Share by Application (2016-2027)
Figure 26. Europe Genetic Testing for Safe Medication Market Share by Country (2016-2027)
Figure 27. Germany Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Genetic Testing for Safe Medication Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Genetic Testing for Safe Medication Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Genetic Testing for Safe Medication Market Share by Region (2016-2027)
Figure 37. China Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Genetic Testing for Safe Medication Market Share by Type (2016-2027)
Figure 45. Latin America Genetic Testing for Safe Medication Market Share by Application (2016-2027)
Figure 46. Latin America Genetic Testing for Safe Medication Market Share by Country (2016-2027)
Figure 47. Mexico Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Genetic Testing for Safe Medication Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Genetic Testing for Safe Medication Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Genetic Testing for Safe Medication Market Share by Country (2016-2027)
Figure 53. Turkey Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Genetic Testing for Safe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Premed Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 57. Inmedi Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 58. Yin Feng Gene Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 59. United Gene Group Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 60. KingMed Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 61. Geneis Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 62. Sansure Revenue Growth Rate in Genetic Testing for Safe Medication Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[安全投薬用遺伝子検査の世界市場規模・現状・予測2021年-2027年] (Global Genetic Testing for Safe Medication Market Size, Status and Forecast 2021-2027 / QY21JNE2256)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆